Medrol 4 mg – DIN 00030988
Medrol is Methylprednisolone 4 mg (tablet), sold in Canada. It is used for adrenal insufficiency, multiple sclerosis and ankylosing spondylitis. It is supplied by Pfizer Canada ULC. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.
Sold in Canada
Methylprednisolone 4 mg
- Brand
- Medrol
- Strength
- 4 mg
- Used for
- Adrenal insufficiency, multiple sclerosis and ankylosing spondylitis
- Form
- Tablet
- Manufacturer
- Pfizer Canada ULC
- Drug class
- Steroid (corticosteroid)
- Sold in
- Canada
- DIN
- 00030988
Source: Health Canada's Drug Product Database. Last checked .
Report a mistake
What is Methylprednisolone used for?
Methylprednisolone is used for adrenal insufficiency, multiple sclerosis, ankylosing spondylitis and lupus.
- Medicine type
- Steroid (corticosteroid)
Official uses from the US prescribing label
Methylprednisolone tablets are indicated in the following conditions:
. Endocrine Disorders
Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance).
Congenital adrenal hyperplasia
Nonsuppurative thyroiditis
Hypercalcemia associated with cancer
. Rheumatic Disorders
As adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in:
Rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy)
Ankylosing spondylitis
Acute and subacute bursitis
Synovitis of osteoarthritis
Acute nonspecific tenosynovitis
Post-traumatic osteoarthritis
Psoriatic arthritis
Epicondylitis
Acute gouty arthritis
. Collagen Diseases
During an exacerbation or as maintenance therapy in selected cases of:
Systemic lupus erythematosus
Systemic dermatomyositis (polymyositis)
Acute rheumatic carditis
. Dermatologic Diseases
Bullous dermatitis herpetiformis
Severe erythema multiforme (Stevens-Johnson syndrome)
Severe seborrheic dermatitis
Exfoliative dermatitis
Mycosis fungoides
Pemphigus
Severe psoriasis
. Allergic States
Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment:
Seasonal or perennial allergic rhinitis
Drug hypersensitivity reactions
Serum sickness
Contact dermatitis
Bronchial asthma
Atopic dermatitis
. Ophthalmic Diseases
Severe acute and chronic allergic and inflammatory processes involving the eye and its adnexa, such as:
Allergic corneal marginal ulcers
Herpes zoster ophthalmicus
Anterior segment inflammation
Diffuse posterior uveitis and choroiditis
Sympathetic ophthalmia
Keratitis
Optic neuritis
Allergic conjunctivitis
Chorioretinitis
Iritis and iridocyclitis
. Respiratory Diseases
Symptomatic sarcoidosis
Berylliosis
Loeffler's syndrome not manageable by other means
Fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate antituberculous chemotherapy
Aspiration pneumonitis
. Hematologic Disorders
Idiopathic thrombocytopenic purpura in adults
Secondary thrombocytopenia in adults
Acquired (autoimmune) hemolytic anemia
Erythroblastopenia (RBC anemia)
Congenital (erythroid) hypoplastic anemia
. Neoplastic Diseases
For palliative management of:
Leukemias and lymphomas in adults
Acute leukemia of childhood
. Edematous States
To induce a diuresis or remission of proteinuria in the nephrotic syndrome, without uremia, of the idiopathic type or that due to lupus erythematosus.
. Gastrointestinal Diseases
To tide the patient over a critical period of the disease in:
Ulcerative colitis
Regional enteritis
. Nervous System
Acute exacerbations of multiple sclerosis
. Miscellaneous
Tuberculous meningitis with subarachnoid block or impending block when used concurrently with appropriate antituberculous chemotherapy.
Trichinosis with neurologic or myocardial involvement.
From the FDA-approved label on DailyMed (published Sep 02, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your medicine? Check the box
- The box or bottle shows DIN 00030988.
- It names Medrol, Methylprednisolone 4 mg.
- A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.
Sold in Canada as Medrol by Pfizer Canada ULC.
In Canada: prescription only.
Ingredients
Active: Methylprednisolone
Other Methylprednisolone pills
-
42 16 V 4
Methylprednisolone 4 mg
White, oval, 8 mm
Used for adrenal insufficiency and multiple sclerosis
- L13 Methylprednisolone 16 mg White, oval, 10 mm Used for adrenal insufficiency and multiple sclerosis
- CE 190 Methylprednisolone 16 mg White, oval, 10 mm Used for adrenal insufficiency and multiple sclerosis
- 918 Methylprednisolone 16 mg White, oval, 10 mm Used for adrenal insufficiency and multiple sclerosis
- Medrol 16 Methylprednisolone 16 mg White, oval, 10 mm Used for adrenal insufficiency and multiple sclerosis
- L10 Methylprednisolone 2 mg White, oval, 7 mm Used for adrenal insufficiency and multiple sclerosis
- Medrol 2 Methylprednisolone 2 mg White, oval, 8 mm Used for adrenal insufficiency and multiple sclerosis
- CE 187 Methylprednisolone 2 mg White, oval, 7 mm Used for adrenal insufficiency and multiple sclerosis